IL17A and Crohn disease: In another study in a murine model of Crohn's disease, UCN could control inflammatory diseases by inhibiting a wide range of inflammatory cytokines such as TNF-α, IFN‐γ, IL-6, IL-1α, IL-1β, IL-12, IL-18, IL-17, and IL-15 [53].